The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
Background Each year, worldwide, about 3 million people die as a result of trauma, many
after reaching hospital. Among trauma patients who do survive to reach hospital, bleeding is …
after reaching hospital. Among trauma patients who do survive to reach hospital, bleeding is …
[引用][C] The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt, E Balogun… - Health Technol …, 2013 - cir.nii.ac.jp
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of
tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding …
tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding …
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats… - Health technology …, 2013 - researchonline.lshtm.ac.uk
BACKGROUND Among trauma patients who survive to reach hospital, exsanguination is a
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
[HTML][HTML] The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and …
I Roberts, H Shakur, T Coats, B Hunt… - Health Technology …, 2013 - europepmc.org
Background Among trauma patients who survive to reach hospital, exsanguination is a
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
[HTML][HTML] The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and …
I Roberts, H Shakur, T Coats, B Hunt… - Health Technology …, 2013 - ncbi.nlm.nih.gov
BACKGROUND Among trauma patients who survive to reach hospital, exsanguination is a
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
[引用][C] The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt… - Health Technology …, 2013 - journalslibrary.nihr.ac.uk
Background Among trauma patients who survive to reach hospital, exsanguination is a
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt, E Balogun… - emerald.com
Background Each year, worldwide, about 3 million people die as a result of trauma, many
after reaching hospital. Among trauma patients who do survive to reach hospital, bleeding is …
after reaching hospital. Among trauma patients who do survive to reach hospital, bleeding is …
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt, E Balogun… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Among trauma patients who survive to reach hospital, exsanguination is a
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
common cause of death. A widely practicable treatment that reduces blood loss after trauma …
[PDF][PDF] the cRasH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt, E Balogun… - neuroinformaticmalaysia.usm.my
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of
tranexamic acid on death, vascular oc Page 1 DOI 10.3310/hta17100 HealtH tecHnology …
tranexamic acid on death, vascular oc Page 1 DOI 10.3310/hta17100 HealtH tecHnology …
[PDF][PDF] the cRasH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion …
I Roberts, H Shakur, T Coats, B Hunt, E Balogun… - researchgate.net
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of
tranexamic acid on death, vascular oc Page 1 DOI 10.3310/hta17100 HealtH tecHnology …
tranexamic acid on death, vascular oc Page 1 DOI 10.3310/hta17100 HealtH tecHnology …